Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
At-Home Transcranial Direct Current Stimulation Helps Attention in Adults with ADHD
08/09/2022
Jolynn Tumolo
Four weeks of daily, home-based transcranial direct current stimulation (tDCS) improved attention in adults with ADHD not taking stimulant medication, according to a small sham-controlled trial.
Four weeks of daily, home-based transcranial direct current stimulation (tDCS) improved attention in adults with ADHD not taking stimulant medication, according to a small sham-controlled trial.
Four weeks of daily, home-based...
08/09/2022
Psych Congress Network
News
Urothelial Carcinoma Molecular Subtype Could Guide Use of Neoadjuvant Chemotherapy
08/09/2022
Jolynn Tumolo
Cancer subtype was associated with different rates of complete pathological response in patients with urothelial carcinoma.
Cancer subtype was associated with different rates of complete pathological response in patients with urothelial carcinoma.
Cancer subtype was associated...
08/09/2022
First Report Managed Care
News
Increased Acne Among Patients With Alopecia Areata Treated With Tofacitinib
08/09/2022
Jolynn Tumolo
Acne exacerbation is an additional observed effect of tofacitinib therapy among patients with alopecia areata.
Acne exacerbation is an additional observed effect of tofacitinib therapy among patients with alopecia areata.
Acne exacerbation is an...
08/09/2022
First Report Managed Care
News
Stem-Cell Transplantation Therapy Beneficial Among Patients With MS
08/08/2022
Jolynn Tumolo
"Current data encourages a broader application of autologous hematopoietic stem-cell transplantation for treating patients with MS while still considering proper patient selection and transplant methods,” wrote researchers.
"Current data encourages a broader application of autologous hematopoietic stem-cell transplantation for treating patients with MS while still considering proper patient selection and transplant methods,” wrote researchers.
"Current data encourages a...
08/08/2022
First Report Managed Care
News
Proton Pump Inhibitors Help Most Pediatric Patients With EoE
08/05/2022
Jolynn Tumolo
Over half of patients with eosinophilic esophagitis who were treated with proton pump inhibitors showed clinical and histological resolution at their second upper gastrointestinal endoscopy.
Over half of patients with eosinophilic esophagitis who were treated with proton pump inhibitors showed clinical and histological resolution at their second upper gastrointestinal endoscopy.
Over half of patients with...
08/05/2022
First Report Managed Care
News
FDA Grants Breakthrough Device Designation to Investigate Deep Brain Stimulation System in TRD
08/04/2022
Jolynn Tumolo
The FDA recently granted Abbott a breakthrough device designation to investigate the use of its deep brain stimulation system for patients with treatment-resistant depression, a form of major depressive disorder.
The FDA recently granted Abbott a breakthrough device designation to investigate the use of its deep brain stimulation system for patients with treatment-resistant depression, a form of major depressive disorder.
The FDA recently granted Abbott...
08/04/2022
Psych Congress Network
News
Blood Pressure Drug Recalled
08/04/2022
Jolynn Tumolo
Jubilant Cadista Pharmaceuticals is voluntarily recalling a prescription medication used to lower blood pressure in patients with hypertension.
Jubilant Cadista Pharmaceuticals is voluntarily recalling a prescription medication used to lower blood pressure in patients with hypertension.
Jubilant Cadista Pharmaceuticals...
08/04/2022
Pharmacy Learning Network
News
Proton Pump Inhibitor Recalled
08/04/2022
Jolynn Tumolo
Prescription proton pump inhibitors are under a Class II recall for failing to meet dissolution specifications.
Prescription proton pump inhibitors are under a Class II recall for failing to meet dissolution specifications.
Prescription proton pump...
08/04/2022
Pharmacy Learning Network
News
Class I Recall for Diabetes Injection Pens
08/04/2022
Jolynn Tumolo
Diabetes injection pens are under a Class I recall because some of the pens may be missing labels.
Diabetes injection pens are under a Class I recall because some of the pens may be missing labels.
Diabetes injection pens are...
08/04/2022
Pharmacy Learning Network
News
Pediatric ADHD, Psychiatric Disorders Medication Lowers Substance Misuse Risk
08/03/2022
Jolynn Tumolo
Treating psychiatric disorders in children and adolescents with psychotropic medication does not increase the risk of SUD. It appears to reduce the risk in individuals with pediatric ADHD, MDD, and psychotic disorders.
Treating psychiatric disorders in children and adolescents with psychotropic medication does not increase the risk of SUD. It appears to reduce the risk in individuals with pediatric ADHD, MDD, and psychotic disorders.
Treating psychiatric disorders...
08/03/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use